Skip to content

SR 38 · New Jersey · 222 · Billy

Skip to content

Home
/
Bills
/
New Jersey
/
222
/
SR 38

New Jersey · 222 session · senate

SR 38Urges NJ DOH to increase public awareness on effects of xylazine.

Status: In committee
Latest action: 2026-01-13 — Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
Primary sponsor: Polistina, Vincent J.

Health, Human Services and Senior Citizens

Track this bill

Sponsors

Polistina, Vincent J. · primaryprimary
Steinhardt, Douglas J. · cosponsor

Versions

IntroducedJan 13, 2026

Legislative history

Public legislative record via Billy. Sign in to track, annotate, and export work product.

About public bill pages Compare Billy New Jersey bill RSS

Jan 13, 2026

Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

Official sources

Version 0PDF HTML

About this page

Is this the official New Jersey bill page?: No — this is Billy’s public legislative record for SR 38. Official source links are listed above when publishers provide them.
Can I track updates?: Yes. Sign in to track SR 38, get alerts, annotate diffs, and export Word work product.